Abstract
The invention provides an agent for modulating the activity of CLEC14A for the use in treating and/or preventing osteopenia and/or osteoporosis.
Original language | English |
---|---|
IPC | WO 2021/069890 A1 |
Publication status | Published - 15 Apr 2021 |
Amy Naylor (Inventor), Roy Bicknell (Inventor)
Research output: Patent
Original language | English |
---|---|
IPC | WO 2021/069890 A1 |
Publication status | Published - 15 Apr 2021 |